Skip to main content
Top
Gepubliceerd in: Journal of Autism and Developmental Disorders 9/2020

02-07-2019 | Original Paper

The SOFIA Study: Negative Multi-center Study of Low Dose Fluoxetine on Repetitive Behaviors in Children and Adolescents with Autistic Disorder

Auteurs: Paul Herscu, Benjamin L. Handen, L. Eugene Arnold, Michael F. Snape, Joel D. Bregman, Lawrence Ginsberg, Robert Hendren, Alexander Kolevzon, Raun Melmed, Mark Mintz, Nancy Minshew, Linmarie Sikich, Ashraf Attalla, Brian King, Thomas Owley, Ann Childress, Harry Chugani, Jean Frazier, Charles Cartwright, Tanya Murphy, the Autism Speaks Autism Clinical Trials Network

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 9/2020

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) that reduces obsessive–compulsive symptoms. There is limited evidence supporting its efficacy for repetitive behaviors (RRBs) in autistic spectrum disorder (ASD). We conducted a randomized controlled trial (RCT) of fluoxetine in 158 individuals with ASD (5–17 years). Following 14 treatment weeks (mean dose 11.8 mg/day), no significant differences were noted on the Children’s Yale-Brown Obsessive Compulsive Scale; the proportion of responders was similar (fluoxetine: 36%; placebo: 41%). There were similar rates of AEs (e.g., insomnia, diarrhea, vomiting); high rates of activation were reported in both groups (fluoxetine: 42%; placebo: 45%). Overly cautious dosing/duration may have prevented attainment of a therapeutic level. Results are consistent with other SSRI RCTs treating RRBs in ASD.
Trial Registration: clinicaltrials.gov Identifier: NCT00515320.
Literatuur
go back to reference American Psychiatric Association (APA). (2000). Diagnostic and statistical manual of mental disorders TR (4th ed.). Arlington, VA: American Psychiatric Publishing. American Psychiatric Association (APA). (2000). Diagnostic and statistical manual of mental disorders TR (4th ed.). Arlington, VA: American Psychiatric Publishing.
go back to reference American Psychiatric Association (APA). (2013). Diagnostic and statistical manual of mental disorders: DSM-5. Arlington, VA: American Psychiatric Publishing. American Psychiatric Association (APA). (2013). Diagnostic and statistical manual of mental disorders: DSM-5. Arlington, VA: American Psychiatric Publishing.
go back to reference Bodfish, J. W., Symons, F. J., Parker, D. E., & Lewis, M. H. (2000). Varieties of repetitive behavior in autism: Comparisons to mental retardation. Journal of Autism and Developmental Disorders, 30, 237–243.PubMed Bodfish, J. W., Symons, F. J., Parker, D. E., & Lewis, M. H. (2000). Varieties of repetitive behavior in autism: Comparisons to mental retardation. Journal of Autism and Developmental Disorders, 30, 237–243.PubMed
go back to reference Brannan, A. M., Heflinger, C. A., & Bickman, L. (1997). The caregiver strain questionnaire: Measuring the impact on the family of living with a child with serious emotional disturbance. Journal of Emotional and Behavioral Disorders, 5(4), 212–222. Brannan, A. M., Heflinger, C. A., & Bickman, L. (1997). The caregiver strain questionnaire: Measuring the impact on the family of living with a child with serious emotional disturbance. Journal of Emotional and Behavioral Disorders, 5(4), 212–222.
go back to reference Chugani, D. C., Muzik, O., Behen, M., Rothermel, R., Janisse, J. J., Lee, J., et al. (1999). Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Annals of Neurology, 45, 287–295.PubMed Chugani, D. C., Muzik, O., Behen, M., Rothermel, R., Janisse, J. J., Lee, J., et al. (1999). Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Annals of Neurology, 45, 287–295.PubMed
go back to reference Cook, E. H., Jr., Rowlett, R., Jaselskis, C., & Leventhal, B. L. (1992). Fluoxetine treatment of children and adults with autistic disorder and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 739–745.PubMed Cook, E. H., Jr., Rowlett, R., Jaselskis, C., & Leventhal, B. L. (1992). Fluoxetine treatment of children and adults with autistic disorder and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 739–745.PubMed
go back to reference Delong, G. R., Ritch, C. R., & Burch, S. (2002). Fluoxetine response in children with autistic spectrum disorders: Correlation with familial major affective disorder and intellectual achievement. Developmental Medicine and Child Neurology, 44(10), 652–659.PubMed Delong, G. R., Ritch, C. R., & Burch, S. (2002). Fluoxetine response in children with autistic spectrum disorders: Correlation with familial major affective disorder and intellectual achievement. Developmental Medicine and Child Neurology, 44(10), 652–659.PubMed
go back to reference Dominick, K. C., Davis, N. O., Lainhart, J., Tager-Flusberg, H., & Folstein, S. (2007). Atypical behaviors in children with autism and children with a history of language impairment. Research in Developmental Disabilities, 28, 145–162.PubMed Dominick, K. C., Davis, N. O., Lainhart, J., Tager-Flusberg, H., & Folstein, S. (2007). Atypical behaviors in children with autism and children with a history of language impairment. Research in Developmental Disabilities, 28, 145–162.PubMed
go back to reference Dunlap, G., Dyer, K., & Koegel, R. L. (1983). Autistic self-stimulation and intertrial interval duration. American Journal of Mental Deficiency, 88, 194–202.PubMed Dunlap, G., Dyer, K., & Koegel, R. L. (1983). Autistic self-stimulation and intertrial interval duration. American Journal of Mental Deficiency, 88, 194–202.PubMed
go back to reference Emslie, G. J., Kennard, B. D., Mayes, T. L., Nightingale-Teresi, J., Carmody, T., Hughes, C. W., et al. (2008). Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. The American Journal of Psychiatry, 165(4), 459–467.PubMedPubMedCentral Emslie, G. J., Kennard, B. D., Mayes, T. L., Nightingale-Teresi, J., Carmody, T., Hughes, C. W., et al. (2008). Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. The American Journal of Psychiatry, 165(4), 459–467.PubMedPubMedCentral
go back to reference Fatemi, S. H., Realmuto, G. M., Khan, L., & Thuras, P. (1998). Fluoxetine in treatment of adolescent patients with autism: A longitudinal open trial. Journal of Autism and Developmental Disorders, 28, 303–307.PubMed Fatemi, S. H., Realmuto, G. M., Khan, L., & Thuras, P. (1998). Fluoxetine in treatment of adolescent patients with autism: A longitudinal open trial. Journal of Autism and Developmental Disorders, 28, 303–307.PubMed
go back to reference Gabriels, R. L., Cuccaro, M. L., Hill, D. E., Ivers, B. J., & Goldson, E. (2005). Repetitive behaviors in autism: Relationships with associated clinical features. Research in Developmental Disabilities, 26, 169–181.PubMed Gabriels, R. L., Cuccaro, M. L., Hill, D. E., Ivers, B. J., & Goldson, E. (2005). Repetitive behaviors in autism: Relationships with associated clinical features. Research in Developmental Disabilities, 26, 169–181.PubMed
go back to reference Guy, W. (1976). ECDEU assessment manual for psychopharmacology, Publication No. 76-338. Washington, DC: U.S. DHEW, NIMH. Guy, W. (1976). ECDEU assessment manual for psychopharmacology, Publication No. 76-338. Washington, DC: U.S. DHEW, NIMH.
go back to reference Heiligenstein, J. H., Hoog, S. L., Wagner, K. D., Findling, R. L., Galil, N., Kaplan, S., et al. (2006). Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: A pilot study. Journal of Child and Adolescent Psychopharmacology, 16(1–2), 207–217. https://doi.org/10.1089/cap.2006.16.207.CrossRefPubMed Heiligenstein, J. H., Hoog, S. L., Wagner, K. D., Findling, R. L., Galil, N., Kaplan, S., et al. (2006). Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: A pilot study. Journal of Child and Adolescent Psychopharmacology, 16(1–2), 207–217. https://​doi.​org/​10.​1089/​cap.​2006.​16.​207.CrossRefPubMed
go back to reference Hollander, E., Phillips, A., Chaplin, W., Zagursky, K., Novotny, S., Wasserman, S., et al. (2005). A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology, 30(3), 582–589.PubMed Hollander, E., Phillips, A., Chaplin, W., Zagursky, K., Novotny, S., Wasserman, S., et al. (2005). A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology, 30(3), 582–589.PubMed
go back to reference Hollander, E., Phillips, A., King, B. H., Guthrie, D., Aman, M. G., Law, P., et al. (2004). Impact of recent findings on study design of future autism clinical trials. CNS Spectrum, 9, 49–56. Hollander, E., Phillips, A., King, B. H., Guthrie, D., Aman, M. G., Law, P., et al. (2004). Impact of recent findings on study design of future autism clinical trials. CNS Spectrum, 9, 49–56.
go back to reference Hollander, E., Soorya, L., Chaplin, W., Swanson, E., Anagnostou, E., Wasserman, S., et al. (2012). A double-blind, placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autistic disorder. American Journal of Psychiatry, 169(3), 292–299.PubMed Hollander, E., Soorya, L., Chaplin, W., Swanson, E., Anagnostou, E., Wasserman, S., et al. (2012). A double-blind, placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autistic disorder. American Journal of Psychiatry, 169(3), 292–299.PubMed
go back to reference Honey, E., Leekam, S., Turner, M., & McConachie, H. (2007). Repetitive behaviour and play in typically developing children and children with autism spectrum disorders. Journal of Autism and Developmental Disorders, 37, 1107–1115.PubMed Honey, E., Leekam, S., Turner, M., & McConachie, H. (2007). Repetitive behaviour and play in typically developing children and children with autism spectrum disorders. Journal of Autism and Developmental Disorders, 37, 1107–1115.PubMed
go back to reference Jiujias, M., Kelley, E., & Hall, L. (2017). Restricted, repetitive behaviors in autism spectrum disorder and obsessive-compulsive disorder: A comparative review. Child Psychiatry and Human Development, 48, 944–959.PubMed Jiujias, M., Kelley, E., & Hall, L. (2017). Restricted, repetitive behaviors in autism spectrum disorder and obsessive-compulsive disorder: A comparative review. Child Psychiatry and Human Development, 48, 944–959.PubMed
go back to reference Joyce, C., Honey, E., Leekam, S. R., Barrett, S. L., & Rodgers, J. (2017). Anxiety, intolerance of uncertainty and restricted and repetitive behaviour: Insights directly from young people with ASD. Journal of Autism and Developmental Disorders, 47, 3789–3802.PubMed Joyce, C., Honey, E., Leekam, S. R., Barrett, S. L., & Rodgers, J. (2017). Anxiety, intolerance of uncertainty and restricted and repetitive behaviour: Insights directly from young people with ASD. Journal of Autism and Developmental Disorders, 47, 3789–3802.PubMed
go back to reference Kanner, L. (1973). Childhood psychosis: Initial studies and new insights. Washington, DC: Winston. Kanner, L. (1973). Childhood psychosis: Initial studies and new insights. Washington, DC: Winston.
go back to reference King, B. H., Hollander, E., Sikich, L., McCracken, J. T., Scahill, L., Bregman, J. D., et al. (2009). Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: Citalopram ineffective in children with autism. Archives of General Psychiatry, 66(6), 583–590.PubMedPubMedCentral King, B. H., Hollander, E., Sikich, L., McCracken, J. T., Scahill, L., Bregman, J. D., et al. (2009). Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: Citalopram ineffective in children with autism. Archives of General Psychiatry, 66(6), 583–590.PubMedPubMedCentral
go back to reference Koegel, R. L., & Covert, A. (1972). The relationship of self-stimulation to learning in autistic children. Journal of Applied Behavior Analysis, 5, 381–387.PubMedPubMedCentral Koegel, R. L., & Covert, A. (1972). The relationship of self-stimulation to learning in autistic children. Journal of Applied Behavior Analysis, 5, 381–387.PubMedPubMedCentral
go back to reference Kogan, M. D., Vladutiu, C. J., Schieve, L. A., Ghandour, R. M., Blumberg, S. J., Zablotsky, B., et al. (2018). The prevalence of parent-reported autism spectrum disorder among US children. Pediatrics, 142(6), 2017–4161. https://doi.org/10.1542/peds.CrossRef Kogan, M. D., Vladutiu, C. J., Schieve, L. A., Ghandour, R. M., Blumberg, S. J., Zablotsky, B., et al. (2018). The prevalence of parent-reported autism spectrum disorder among US children. Pediatrics, 142(6), 2017–4161. https://​doi.​org/​10.​1542/​peds.CrossRef
go back to reference Kolevzon, A., Mathewson, K. A., & Hollander, E. (2006). Selective serotonin reuptake inhibitors in autism: A review of efficacy and tolerability. Journal of Clinical Psychiatry, 67, 407–414.PubMed Kolevzon, A., Mathewson, K. A., & Hollander, E. (2006). Selective serotonin reuptake inhibitors in autism: A review of efficacy and tolerability. Journal of Clinical Psychiatry, 67, 407–414.PubMed
go back to reference Lam, K. S. L., & Aman, M. G. (2007). The repetitive behavior scale-revised: Independent validation in individuals with autism spectrum disorders. Journal of Autism and Developmental Disorders, 37, 855–866.PubMed Lam, K. S. L., & Aman, M. G. (2007). The repetitive behavior scale-revised: Independent validation in individuals with autism spectrum disorders. Journal of Autism and Developmental Disorders, 37, 855–866.PubMed
go back to reference Lam, K. S. L., Bodfish, J. W., & Piven, J. (2008). Evidence for three subtypes of repetitive behavior in autism that differ in familiarity and association with other symptoms. Journal of Child Psychology and Psychiatry, 49, 1193–1200.PubMed Lam, K. S. L., Bodfish, J. W., & Piven, J. (2008). Evidence for three subtypes of repetitive behavior in autism that differ in familiarity and association with other symptoms. Journal of Child Psychology and Psychiatry, 49, 1193–1200.PubMed
go back to reference Langen, M., Schnack, H. G., Nederveen, H., Bos, D., Lahuis, B. E., de Jonge, M. V., et al. (2009). Chnages in the developmental trajectories of striatum in autism. Biological Psychiatry, 66(4), 327–333.PubMed Langen, M., Schnack, H. G., Nederveen, H., Bos, D., Lahuis, B. E., de Jonge, M. V., et al. (2009). Chnages in the developmental trajectories of striatum in autism. Biological Psychiatry, 66(4), 327–333.PubMed
go back to reference Lecavalier, L. (2006). Behavioral and emotional problems in young people with pervasive developmental disorders: Relative prevalence, effects of subject characteristics, and empirical classification. Journal of Autism and Developmental Disorders, 36, 1101–1114.PubMed Lecavalier, L. (2006). Behavioral and emotional problems in young people with pervasive developmental disorders: Relative prevalence, effects of subject characteristics, and empirical classification. Journal of Autism and Developmental Disorders, 36, 1101–1114.PubMed
go back to reference Lewin, A. B., Wood, J. J., Gunderson, S., Murphy, T. K., & Storch, E. A. (2011). Phenomenology of comorbid autism spectrum and obsessive-compulsive disorders among children. Journal of Developmental and Physical Disabilities, 23(6), 543–553. Lewin, A. B., Wood, J. J., Gunderson, S., Murphy, T. K., & Storch, E. A. (2011). Phenomenology of comorbid autism spectrum and obsessive-compulsive disorders among children. Journal of Developmental and Physical Disabilities, 23(6), 543–553.
go back to reference Liebowitz, M. R., Turner, S. M., Piacentini, J., Beidel, D. C., Clarvit, S. R., Davies, S. O., et al. (2002). Fluoxetine in children and adolescents with OCD: A placebo-controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 41(12), 1431–1438.PubMed Liebowitz, M. R., Turner, S. M., Piacentini, J., Beidel, D. C., Clarvit, S. R., Davies, S. O., et al. (2002). Fluoxetine in children and adolescents with OCD: A placebo-controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 41(12), 1431–1438.PubMed
go back to reference Lord, C., DiLavorne, P. C., & Risi, S. (2002). Autism diagnostic observation schedule. Torrance, CA: Western Psychological Services. Lord, C., DiLavorne, P. C., & Risi, S. (2002). Autism diagnostic observation schedule. Torrance, CA: Western Psychological Services.
go back to reference Lord, C., Rutter, M., DiLavore, P. C., Risi, S., Gotham, K., & Bishop, S. L. (2012). Autism diagnostic observation schedule (ADOS-2) (2nd ed.). Torrance, CA: Western Psychological Services. Lord, C., Rutter, M., DiLavore, P. C., Risi, S., Gotham, K., & Bishop, S. L. (2012). Autism diagnostic observation schedule (ADOS-2) (2nd ed.). Torrance, CA: Western Psychological Services.
go back to reference Lord, C., Rutter, M., & Le Couteur, A. (1994). Autism diagnostic interview-revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders, 24, 659–685.PubMed Lord, C., Rutter, M., & Le Couteur, A. (1994). Autism diagnostic interview-revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders, 24, 659–685.PubMed
go back to reference Madden, J. M., Lakoma, M. D., Lynch, F. L., Rusinak, D., Owen-Smith, A. A., Coleman, K. J., et al. (2017). Psychotropic medication use among insured children with autism spectrum disorder. Journal of Autism and Developmental Disorders, 47, 144–154.PubMedPubMedCentral Madden, J. M., Lakoma, M. D., Lynch, F. L., Rusinak, D., Owen-Smith, A. A., Coleman, K. J., et al. (2017). Psychotropic medication use among insured children with autism spectrum disorder. Journal of Autism and Developmental Disorders, 47, 144–154.PubMedPubMedCentral
go back to reference Markarian, Y., Larson, M. J., Aldea, M. A., Baldwin, S. A., Good, D., Berkeljon, A., et al. (2010). Multiple pathways to functional impairment in obsessive-compulsive disorder. Clinical Psychology Review, 30(1), 78–88.PubMed Markarian, Y., Larson, M. J., Aldea, M. A., Baldwin, S. A., Good, D., Berkeljon, A., et al. (2010). Multiple pathways to functional impairment in obsessive-compulsive disorder. Clinical Psychology Review, 30(1), 78–88.PubMed
go back to reference McDougle, C., Kresch, L. E., Goodman, W. K., Naylor, S. T., & Volkmar, F. R. (1995). A case-controlled study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder. American Journal of Psychiatry, 152, 773. McDougle, C., Kresch, L. E., Goodman, W. K., Naylor, S. T., & Volkmar, F. R. (1995). A case-controlled study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder. American Journal of Psychiatry, 152, 773.
go back to reference Meyer, J. H. (2004). Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: An [11C]DASB positron emission tomography study. American Journal of Psychiatry, 161, 826–835.PubMed Meyer, J. H. (2004). Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: An [11C]DASB positron emission tomography study. American Journal of Psychiatry, 161, 826–835.PubMed
go back to reference Morrison, K., & Rosales-Ruiz, J. (1997). The effect of object preferences on task performance and stereotypy in a child with autism. Research in Developmental Disabilities, 18, 127–137.PubMed Morrison, K., & Rosales-Ruiz, J. (1997). The effect of object preferences on task performance and stereotypy in a child with autism. Research in Developmental Disabilities, 18, 127–137.PubMed
go back to reference Novotny, S., Hollander, E., Phillips, A., Allen, A., Wasserman, S., & Iyengar, R. (2004). Increased repetitive behaviours and prolactin responsivity to oral m-chlorophenylpiperazine in adults with autism spectrum disorders. International Journal of Neuropsychopharmacology, 7(3), 249–254.PubMed Novotny, S., Hollander, E., Phillips, A., Allen, A., Wasserman, S., & Iyengar, R. (2004). Increased repetitive behaviours and prolactin responsivity to oral m-chlorophenylpiperazine in adults with autism spectrum disorders. International Journal of Neuropsychopharmacology, 7(3), 249–254.PubMed
go back to reference Preskorn, S. (2011). What do the terms “Drug-specific response/remission rate” and “Placebo” really mean? Journal of Psychiatric Practice, 17(6), 420–424.PubMed Preskorn, S. (2011). What do the terms “Drug-specific response/remission rate” and “Placebo” really mean? Journal of Psychiatric Practice, 17(6), 420–424.PubMed
go back to reference Preskorn, S. (2012). The use of biomarkers in psychiatric research: How serotonin transporter occupancy explains the dose-response curves of SSRIs. Journal of Psychiatric Practice, 18(1), 38–45.PubMed Preskorn, S. (2012). The use of biomarkers in psychiatric research: How serotonin transporter occupancy explains the dose-response curves of SSRIs. Journal of Psychiatric Practice, 18(1), 38–45.PubMed
go back to reference Riddle, M. A., Scahill, L., King, R. A., Hardin, M. T., Anderson, G. M., Ort, S. I., et al. (1992). Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 31(6), 1062–1069.PubMed Riddle, M. A., Scahill, L., King, R. A., Hardin, M. T., Anderson, G. M., Ort, S. I., et al. (1992). Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 31(6), 1062–1069.PubMed
go back to reference Rodgers, J., Glod, M., Connolly, B., & McConachie, H. (2012). The relationship between anxiety and repetitive behaviors in autism spectrum disorder. Journal of Autism and Developmental Disorders, 42, 2404–2409.PubMed Rodgers, J., Glod, M., Connolly, B., & McConachie, H. (2012). The relationship between anxiety and repetitive behaviors in autism spectrum disorder. Journal of Autism and Developmental Disorders, 42, 2404–2409.PubMed
go back to reference Runco, M. A., Charlop, M. H., & Schreibman, L. (1986). The occurrence of autistic children’s self-stimulation as a function of familiar versus unfamiliar stimulus conditions. Journal of Autism and Developmental Disorders, 16, 31–44.PubMed Runco, M. A., Charlop, M. H., & Schreibman, L. (1986). The occurrence of autistic children’s self-stimulation as a function of familiar versus unfamiliar stimulus conditions. Journal of Autism and Developmental Disorders, 16, 31–44.PubMed
go back to reference Rutter, M., Le Couteur, A., & Lord, C. (2003). ADI-R: Autism diagnostic interview-revised (ADI-R). Los Angeles, CA: Western Psychological Services. Rutter, M., Le Couteur, A., & Lord, C. (2003). ADI-R: Autism diagnostic interview-revised (ADI-R). Los Angeles, CA: Western Psychological Services.
go back to reference Ruzzano, L., Borsboom, D., & Geurts, H. M. (2015). Repetitive behaviors in autism and obsessive-compulsive disorder: New perspectives from a network analysis. Journal of Autism and Developmental Disorders, 45, 192–202.PubMed Ruzzano, L., Borsboom, D., & Geurts, H. M. (2015). Repetitive behaviors in autism and obsessive-compulsive disorder: New perspectives from a network analysis. Journal of Autism and Developmental Disorders, 45, 192–202.PubMed
go back to reference Scahill, L., McDougle, C. J., Williams, S. K., Dimitropoulos, A., Aman, M. G., McCracken, J. T., et al. (2006). Children’s Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 45(9), 1114–1123.PubMed Scahill, L., McDougle, C. J., Williams, S. K., Dimitropoulos, A., Aman, M. G., McCracken, J. T., et al. (2006). Children’s Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 45(9), 1114–1123.PubMed
go back to reference Sonawalla, S. B., & Rosenbaum, J. F. (2002). Placebo response in depression. Dialogues in Clinical Neuroscience, 4(1), 105–113.PubMedPubMedCentral Sonawalla, S. B., & Rosenbaum, J. F. (2002). Placebo response in depression. Dialogues in Clinical Neuroscience, 4(1), 105–113.PubMedPubMedCentral
Metagegevens
Titel
The SOFIA Study: Negative Multi-center Study of Low Dose Fluoxetine on Repetitive Behaviors in Children and Adolescents with Autistic Disorder
Auteurs
Paul Herscu
Benjamin L. Handen
L. Eugene Arnold
Michael F. Snape
Joel D. Bregman
Lawrence Ginsberg
Robert Hendren
Alexander Kolevzon
Raun Melmed
Mark Mintz
Nancy Minshew
Linmarie Sikich
Ashraf Attalla
Brian King
Thomas Owley
Ann Childress
Harry Chugani
Jean Frazier
Charles Cartwright
Tanya Murphy
the Autism Speaks Autism Clinical Trials Network
Publicatiedatum
02-07-2019
Uitgeverij
Springer US
Gepubliceerd in
Journal of Autism and Developmental Disorders / Uitgave 9/2020
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI
https://doi.org/10.1007/s10803-019-04120-y

Andere artikelen Uitgave 9/2020

Journal of Autism and Developmental Disorders 9/2020 Naar de uitgave